MedPath

Non-syndromic Inherited Anomalies of Mineralized Tooth Tissues: a Whole Exome Study to Identify New Pathogenic Variants

Not Applicable
Conditions
Dentin Anomalies
Amelogenesis Imperfecta
Dentinogenesis Imperfecta
Interventions
Biological: Blood sample
Registration Number
NCT03810859
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

ExoDent specifically aims to discover new genes and new mutations causing isolated amelogenesis imperfecta (AI) and dentinogenesis imperfecta (DI) and other dentin anomalies. The key point for clinicians is to distinguish between non syndromic and syndromic disorders in order to improve patients guidance and counseling. To do so, two targeted NGS panel have been designed, one searching for isolated AI and the other for DI. After 18 months, some families remain without any positive results. ExoDent project proposes those negative patients a Whole Exome Sequencing (WES) approach to deeper explore their genetic background.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
14
Inclusion Criteria
  • clinical diagnosis of amelogenesis imperfecta or dentinogenesis imerfecta or other dentin anomaly with no other signs or symptoms ( familial or isolated)
  • negative results after targeted NGS strategy for molecular diagnosis
Exclusion Criteria
  • absence of positive clinical diagnosis
  • Diagnosis of syndromic disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
All patientsBlood sampleBlood sample
Primary Outcome Measures
NameTimeMethod
Genome sequencingAfter one day

Pathogenic variants identification and qualification

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hospital Cochin

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath